Cancer type affects quality of care survivors receive

Cancer type affects quality of care survivors receive
Compared with control patients without cancer, survivors of some cancers receive different quality of care on certain chronic and acute indicators, according to research published online Feb. 11 in the Journal of Clinical Oncology.

(HealthDay)—Compared with control patients without cancer, survivors of some cancers receive different quality of care on certain chronic and acute indicators, according to research published online Feb. 11 in the Journal of Clinical Oncology.

Claire F. Snyder, Ph.D., of the Johns Hopkins School of Medicine in Baltimore, Md., and colleagues used data from the Surveillance, Epidemiology, and End Results-Medicare database to assess the quality of chronic and acute condition care for 8,661 cancer survivors who were diagnosed in 2004 (aged 66 years or older) and survived three or more years. Cases were compared with 17,322 controls (mean age, 75 years) to examine the proportions receiving recommended care.

The researchers found that, compared with controls, colorectal cancer survivors were significantly less likely to receive appropriate care on chronic and acute indicators (odds ratio [OR], 0.88 and 0.72, respectively). For prostate cancer survivors, quality care was more likely for chronic indicators (OR, 1.28) and less likely for acute indicators (OR, 0.75). Compared with controls, for , there was no significant difference in the quality of care for chronic or acute indicators.

"These results have several important implications. First, in terms of survivorship research, these findings indicate that analyses combining multiple may not be appropriate," the authors write. "In terms of clinical implications, these results suggest that there may be certain groups (e.g., colorectal cancer survivors) that are less likely to receive appropriate care."

One of the authors disclosed to Eviti.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Adherence to cancer surveillance guidelines varies

Mar 30, 2012

(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo ...

Young cancer survivors often forgo medical care due to costs

Sep 24, 2012

Many survivors of adolescent and young adult cancers avoid routine medical care because it's too expensive, despite the fact that most have health insurance. That is the conclusion of a new study published early online in ...

Recommended for you

Cancerous tumors may spread by pure chance

2 hours ago

The spreading of a cancerous tumor from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown.

Lanreotide improves survival with enteropancreatic tumors

19 hours ago

(HealthDay)—Lanreotide significantly improves survival among patients with metastatic enteropancreatic neuroendocrine tumors (grade 1 or 2), according to a study published in the July 17 issue of the New En ...

User comments